Eris Lifesciences Limited has informed the Exchange regarding 'Corporate Presentation'.
ERIS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Eris Lifesciences has informed the stock exchanges that a Corporate Presentation has been uploaded on its company website (eris.co.in/eris-at-a-glance/). The disclosure is made under Regulation 30 of SEBI (LODR) Regulations, 2015. The letter is signed by Milind Talegaonkar, Company Secretary and Compliance Officer. No specific financial numbers, targets, or business updates are provided in the filing itself — only a link to the presentation. The actual content of the presentation would need to be reviewed separately to extract any business or financial insights.
Routine regulatory disclosure with no direct impact on the stock price. Investors interested in the company's strategy, metrics, or outlook should review the linked corporate presentation for details.